Gabapentin
Pricing Report NDC 51991-338-05

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Gabapentin (NDC 51991-338-05) is $0.05145 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 20, 2014.

As a provided by Breckenridge Pharmaceutical, Inc., this medication is distributed in a 500 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.05145
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 20, 2014
Billable Units
500 EA
Estimated Package Price
$25.72
Data Status
As of Sep 10, 2014
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
51991-338-05
Description
500 CAPSULE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $0.05145 to $0.06764 per EA. Over this 8 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.0515 - $0.0676
Market Volatility
31.47% Variance
Latest Trend
2.72%
Date Unit Price Unit Source Method Rate
Aug 20, 2014 $0.05145 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Aug 20, 2014 $0.05145 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 23, 2014 $0.05289 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jul 23, 2014 $0.05289 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jun 18, 2014 $0.05307 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jun 18, 2014 $0.05307 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 21, 2014 $0.05771 EAC/I - Chain or Independent PharmacyCode 1G - Generic
May 21, 2014 $0.05771 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 23, 2014 $0.05500 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Apr 23, 2014 $0.05500 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $0.05517 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Mar 19, 2014 $0.05517 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 05, 2014 $0.05841 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2014 $0.05841 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Jan 22, 2014 $0.06764 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Dec 18, 2013 $0.05720 EAC/I - Chain or Independent PharmacyCode 1G - Generic
Nov 21, 2013 $0.05637 EAC/I - Chain or Independent PharmacyCode 1G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026